アジソン病治療薬の世界市場 2024-2028年

アジソン病治療薬市場 2024-2028年

アジソン病治療薬市場は2023-2028年に4億4,240万米ドル、予測期間中のCAGRは6.59%で成長すると予測されます。当レポートでは、アジソン病治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、特効薬指定、医薬品の再製剤化、有利な償還シナリオによって牽引されています。

本調査では、今後数年間のアジソン病治療薬市場成長を牽引する主要因の1つとして、再生療法開発の研究拡大を挙げています。また、臨床ガイドラインの利用可能性や病態生理学の再定義が市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• アジソン病治療薬の世界市場 2018-2022
• 治療別セグメント分析 2018-2022
• エンドユーザー別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：治療別

• 市場セグメンテーション
• 比較：治療別
• 経口薬：市場規模と予測 2023-2028
• 非経口薬：市場規模と予測 2023-2028
• 治療別の市場機会

第7章 市場セグメンテーション：エンドユーザー別

• 市場セグメンテーション
• 比較：エンドユーザー別
• 病院と診療所：市場規模と予測 2023-2028
• 診断検査室：市場規模と予測 2023-2028
• エンドユーザー別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 地域情勢別市場機会

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• Abbott Laboratories
• Actiza Pharmaceutical Pvt. Ltd.
• Akorn Operating Co LLC
• Amgen Inc.
• Amneal Pharmaceuticals Inc.
• Bayer AG
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• GlaxoSmithKline Plc
• Hikma Pharmaceuticals Plc
• Merck and Co. Inc.
• Neurocrine Biosciences Inc.
• Novartis AG
• Pfizer Inc.
• Takeda Pharmaceutical Co. Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Addisons Disease Therapeutics Market 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Therapy - Market share 2023-2028 (%)
• Exhibits33: Data Table on Therapy - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Therapy
• Exhibits35: Data Table on Comparison by Therapy
• Exhibits36: Chart on Oral drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Data Table on Oral drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits38: Chart on Oral drugs - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Oral drugs - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Parenteral drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Data Table on Parenteral drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits42: Chart on Parenteral drugs - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Parenteral drugs - Year-over-year growth 2023-2028 (%)
• Exhibits44: Market opportunity by Therapy ($ million)
• Exhibits45: Data Table on Market opportunity by Therapy ($ million)
• Exhibits46: Chart on End-user - Market share 2023-2028 (%)
• Exhibits47: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits48: Chart on Comparison by End-user
• Exhibits49: Data Table on Comparison by End-user
• Exhibits50: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits52: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
• Exhibits54: Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
• Exhibits56: Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
• Exhibits58: Market opportunity by End-user ($ million)
• Exhibits59: Data Table on Market opportunity by End-user ($ million)
• Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits63: Chart on Geographic comparison
• Exhibits64: Data Table on Geographic comparison
• Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits101: Market opportunity By Geographical Landscape ($ million)
• Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits103: Impact of drivers and challenges in 2023 and 2028
• Exhibits104: Overview on criticality of inputs and factors of differentiation
• Exhibits105: Overview on factors of disruption
• Exhibits106: Impact of key risks on business
• Exhibits107: Companies covered
• Exhibits108: Matrix on companies position and classification
• Exhibits109: Abbott Laboratories - Overview
• Exhibits110: Abbott Laboratories - Business segments
• Exhibits111: Abbott Laboratories - Key news
• Exhibits112: Abbott Laboratories - Key offerings
• Exhibits113: Abbott Laboratories - Segment focus
• Exhibits114: Actiza Pharmaceutical Pvt. Ltd. - Overview
• Exhibits115: Actiza Pharmaceutical Pvt. Ltd. - Product / Service
• Exhibits116: Actiza Pharmaceutical Pvt. Ltd. - Key offerings
• Exhibits117: Akorn Operating Co LLC - Overview
• Exhibits118: Akorn Operating Co LLC - Product / Service
• Exhibits119: Akorn Operating Co LLC - Key offerings
• Exhibits120: Amgen Inc. - Overview
• Exhibits121: Amgen Inc. - Product / Service
• Exhibits122: Amgen Inc. - Key news
• Exhibits123: Amgen Inc. - Key offerings
• Exhibits124: Amneal Pharmaceuticals Inc. - Overview
• Exhibits125: Amneal Pharmaceuticals Inc. - Business segments
• Exhibits126: Amneal Pharmaceuticals Inc. - Key news
• Exhibits127: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibits128: Amneal Pharmaceuticals Inc. - Segment focus
• Exhibits129: Bayer AG - Overview
• Exhibits130: Bayer AG - Business segments
• Exhibits131: Bayer AG - Key news
• Exhibits132: Bayer AG - Key offerings
• Exhibits133: Bayer AG - Segment focus
• Exhibits134: Bristol Myers Squibb Co. - Overview
• Exhibits135: Bristol Myers Squibb Co. - Product / Service
• Exhibits136: Bristol Myers Squibb Co. - Key news
• Exhibits137: Bristol Myers Squibb Co. - Key offerings
• Exhibits138: Eli Lilly and Co. - Overview
• Exhibits139: Eli Lilly and Co. - Product / Service
• Exhibits140: Eli Lilly and Co. - Key news
• Exhibits141: Eli Lilly and Co. - Key offerings
• Exhibits142: GlaxoSmithKline Plc - Overview
• Exhibits143: GlaxoSmithKline Plc - Business segments
• Exhibits144: GlaxoSmithKline Plc - Key news
• Exhibits145: GlaxoSmithKline Plc - Key offerings
• Exhibits146: GlaxoSmithKline Plc - Segment focus
• Exhibits147: Hikma Pharmaceuticals Plc - Overview
• Exhibits148: Hikma Pharmaceuticals Plc - Business segments
• Exhibits149: Hikma Pharmaceuticals Plc - Key news
• Exhibits150: Hikma Pharmaceuticals Plc - Key offerings
• Exhibits151: Hikma Pharmaceuticals Plc - Segment focus
• Exhibits152: Merck and Co. Inc. - Overview
• Exhibits153: Merck and Co. Inc. - Business segments
• Exhibits154: Merck and Co. Inc. - Key news
• Exhibits155: Merck and Co. Inc. - Key offerings
• Exhibits156: Merck and Co. Inc. - Segment focus
• Exhibits157: Neurocrine Biosciences Inc. - Overview
• Exhibits158: Neurocrine Biosciences Inc. - Product / Service
• Exhibits159: Neurocrine Biosciences Inc. - Key offerings
• Exhibits160: Novartis AG - Overview
• Exhibits161: Novartis AG - Business segments
• Exhibits162: Novartis AG - Key news
• Exhibits163: Novartis AG - Key offerings
• Exhibits164: Novartis AG - Segment focus
• Exhibits165: Pfizer Inc. - Overview
• Exhibits166: Pfizer Inc. - Product / Service
• Exhibits167: Pfizer Inc. - Key news
• Exhibits168: Pfizer Inc. - Key offerings
• Exhibits169: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits170: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits171: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits172: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits173: Inclusions checklist
• Exhibits174: Exclusions checklist
• Exhibits175: Currency conversion rates for US$
• Exhibits176: Research methodology
• Exhibits177: Information sources
• Exhibits178: Data validation
• Exhibits179: Validation techniques employed for market sizing
• Exhibits180: Data synthesis
• Exhibits181: 360 degree market analysis
• Exhibits182: List of abbreviations

Addisons Disease Therapeutics Market 2024-2028

The addisons disease therapeutics market is forecasted to grow by USD 442.4 mn during 2023-2028, accelerating at a CAGR of 6.59% during the forecast period. The report on the addisons disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by special drug designations, reformulation of drugs, and favourable reimbursement scenario.

Technavio's addisons disease therapeutics market is segmented as below:

By Therapy

• Oral drugs
• Parenteral drugs

By End-user

• Hospitals and clinics
• Diagnostic laboratories

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the expanding research into development of regenerative therapy as one of the prime reasons driving the addisons disease therapeutics market growth during the next few years. Also, availability of clinical guidelines and redefined pathophysiology will lead to sizable demand in the market.

The report on the addisons disease therapeutics market covers the following areas:

• Addisons disease therapeutics market sizing
• Addisons disease therapeutics market forecast
• Addisons disease therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading addisons disease therapeutics market vendors that include Abbott Laboratories, Actiza Pharmaceutical Pvt. Ltd., Akorn Operating Co LLC, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Bio Techne Corp., Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., BTL Biotechno Labs Pvt. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd., Merck and Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the addisons disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Therapy
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Addisons Disease Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Addisons Disease Therapeutics Market 2018 - 2022 ($ million)
• 4.2 Therapy segment analysis 2018 - 2022
  • Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
• 4.3 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy

• 6.1 Market segments
  • Chart on Therapy - Market share 2023-2028 (%)
  • Data Table on Therapy - Market share 2023-2028 (%)
• 6.2 Comparison by Therapy
  • Chart on Comparison by Therapy
  • Data Table on Comparison by Therapy
• 6.3 Oral drugs - Market size and forecast 2023-2028
  • Chart on Oral drugs - Market size and forecast 2023-2028 ($ million)
  • Data Table on Oral drugs - Market size and forecast 2023-2028 ($ million)
  • Chart on Oral drugs - Year-over-year growth 2023-2028 (%)
  • Data Table on Oral drugs - Year-over-year growth 2023-2028 (%)
• 6.4 Parenteral drugs - Market size and forecast 2023-2028
  • Chart on Parenteral drugs - Market size and forecast 2023-2028 ($ million)
  • Data Table on Parenteral drugs - Market size and forecast 2023-2028 ($ million)
  • Chart on Parenteral drugs - Year-over-year growth 2023-2028 (%)
  • Data Table on Parenteral drugs - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Therapy
  • Market opportunity by Therapy ($ million)
  • Data Table on Market opportunity by Therapy ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 7.3 Hospitals and clinics - Market size and forecast 2023-2028
  • Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
• 7.4 Diagnostic laboratories - Market size and forecast 2023-2028
  • Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
  • Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
  • Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
  • Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.11 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
• 12.4 Actiza Pharmaceutical Pvt. Ltd.
  • Actiza Pharmaceutical Pvt. Ltd. - Overview
  • Actiza Pharmaceutical Pvt. Ltd. - Product / Service
  • Actiza Pharmaceutical Pvt. Ltd. - Key offerings
• 12.5 Akorn Operating Co LLC
  • Akorn Operating Co LLC - Overview
  • Akorn Operating Co LLC - Product / Service
  • Akorn Operating Co LLC - Key offerings
• 12.6 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
• 12.7 Amneal Pharmaceuticals Inc.
  • Amneal Pharmaceuticals Inc. - Overview
  • Amneal Pharmaceuticals Inc. - Business segments
  • Amneal Pharmaceuticals Inc. - Key news
  • Amneal Pharmaceuticals Inc. - Key offerings
  • Amneal Pharmaceuticals Inc. - Segment focus
• 12.8 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
• 12.9 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
• 12.10 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key news
  • Eli Lilly and Co. - Key offerings
• 12.11 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 12.12 Hikma Pharmaceuticals Plc
  • Hikma Pharmaceuticals Plc - Overview
  • Hikma Pharmaceuticals Plc - Business segments
  • Hikma Pharmaceuticals Plc - Key news
  • Hikma Pharmaceuticals Plc - Key offerings
  • Hikma Pharmaceuticals Plc - Segment focus
• 12.13 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 12.14 Neurocrine Biosciences Inc.
  • Neurocrine Biosciences Inc. - Overview
  • Neurocrine Biosciences Inc. - Product / Service
  • Neurocrine Biosciences Inc. - Key offerings
• 12.15 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 12.16 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
• 12.17 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations